Cargando…

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda

BACKGROUND: We aimed to assess the relationship between gender and survival among adult patients newly enrolled on antiretroviral therapy (ART) in Uganda. We also specifically examined the role of antenatal services in favoring women’s access to HIV care. METHODS: From an observational cohort study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanters, Steve, Nansubuga, Margaret, Mwehire, Daniel, Odiit, Mary, Kasirye, Margaret, Musoke, William, Druyts, Eric, Yaya, Sanni, Funk, Anna, Ford, Nathan, Mills, Edward J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677809/
https://www.ncbi.nlm.nih.gov/pubmed/23766660
http://dx.doi.org/10.2147/HIV.S42521
_version_ 1782272763900198912
author Kanters, Steve
Nansubuga, Margaret
Mwehire, Daniel
Odiit, Mary
Kasirye, Margaret
Musoke, William
Druyts, Eric
Yaya, Sanni
Funk, Anna
Ford, Nathan
Mills, Edward J
author_facet Kanters, Steve
Nansubuga, Margaret
Mwehire, Daniel
Odiit, Mary
Kasirye, Margaret
Musoke, William
Druyts, Eric
Yaya, Sanni
Funk, Anna
Ford, Nathan
Mills, Edward J
author_sort Kanters, Steve
collection PubMed
description BACKGROUND: We aimed to assess the relationship between gender and survival among adult patients newly enrolled on antiretroviral therapy (ART) in Uganda. We also specifically examined the role of antenatal services in favoring women’s access to HIV care. METHODS: From an observational cohort study, we assessed survival and used logistic regression and differences in means to compare men and women who did not access care through antenatal services. Differences were assessed on measures of disease progression (WHO stage and CD4 count) and demographic (age, marital status, and education), behavioral (sexual activity, disclosure to partner, and testing), and clinical variables (hepatitis B and C, syphilis, malaria, and anemia). A mediational analysis that considered gender as the initial variable, time to death as the outcome, initial CD4 count as the mediator, and age as a covariate was performed using an accelerated failure time model with a Weibull distribution. RESULTS: Between 2004 and 2011, a total of 4775 patients initiated ART, and after exclusions 4537 (93.2%) were included in analysis. Men initiating ART were more likely to have a WHO disease stage III or IV (odds ratio: 1.46, 95% confidence interval [CI]: 1.29–1.66), and lower CD4 cell counts compared to women (median baseline CD4 124 cells/mm(3), interquartile range [IQR]: 43–205 versus 147 cells/mm(3), IQR: 68–212, P-value < 0.0001). Men were at an increased risk of death compared to women (hazard ratio: 1.38, 95% CI: 1.03–1.83). Baseline CD4 cell counts accounted for 43% of the increased risk of death in men (95% CI: 22%–113%). Access to care via antenatal services did not explain differences in outcomes. CONCLUSION: In this cohort there is a marked increase in risk of mortality for men and approximately half of it can be attributed to their later engagement in care. More effort is required to engage men in care in a timely manner.
format Online
Article
Text
id pubmed-3677809
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36778092013-06-13 Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda Kanters, Steve Nansubuga, Margaret Mwehire, Daniel Odiit, Mary Kasirye, Margaret Musoke, William Druyts, Eric Yaya, Sanni Funk, Anna Ford, Nathan Mills, Edward J HIV AIDS (Auckl) Original Research BACKGROUND: We aimed to assess the relationship between gender and survival among adult patients newly enrolled on antiretroviral therapy (ART) in Uganda. We also specifically examined the role of antenatal services in favoring women’s access to HIV care. METHODS: From an observational cohort study, we assessed survival and used logistic regression and differences in means to compare men and women who did not access care through antenatal services. Differences were assessed on measures of disease progression (WHO stage and CD4 count) and demographic (age, marital status, and education), behavioral (sexual activity, disclosure to partner, and testing), and clinical variables (hepatitis B and C, syphilis, malaria, and anemia). A mediational analysis that considered gender as the initial variable, time to death as the outcome, initial CD4 count as the mediator, and age as a covariate was performed using an accelerated failure time model with a Weibull distribution. RESULTS: Between 2004 and 2011, a total of 4775 patients initiated ART, and after exclusions 4537 (93.2%) were included in analysis. Men initiating ART were more likely to have a WHO disease stage III or IV (odds ratio: 1.46, 95% confidence interval [CI]: 1.29–1.66), and lower CD4 cell counts compared to women (median baseline CD4 124 cells/mm(3), interquartile range [IQR]: 43–205 versus 147 cells/mm(3), IQR: 68–212, P-value < 0.0001). Men were at an increased risk of death compared to women (hazard ratio: 1.38, 95% CI: 1.03–1.83). Baseline CD4 cell counts accounted for 43% of the increased risk of death in men (95% CI: 22%–113%). Access to care via antenatal services did not explain differences in outcomes. CONCLUSION: In this cohort there is a marked increase in risk of mortality for men and approximately half of it can be attributed to their later engagement in care. More effort is required to engage men in care in a timely manner. Dove Medical Press 2013-05-29 /pmc/articles/PMC3677809/ /pubmed/23766660 http://dx.doi.org/10.2147/HIV.S42521 Text en © 2013 Kanters et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Kanters, Steve
Nansubuga, Margaret
Mwehire, Daniel
Odiit, Mary
Kasirye, Margaret
Musoke, William
Druyts, Eric
Yaya, Sanni
Funk, Anna
Ford, Nathan
Mills, Edward J
Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title_full Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title_fullStr Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title_full_unstemmed Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title_short Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
title_sort increased mortality among hiv-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677809/
https://www.ncbi.nlm.nih.gov/pubmed/23766660
http://dx.doi.org/10.2147/HIV.S42521
work_keys_str_mv AT kanterssteve increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT nansubugamargaret increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT mwehiredaniel increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT odiitmary increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT kasiryemargaret increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT musokewilliam increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT druytseric increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT yayasanni increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT funkanna increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT fordnathan increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda
AT millsedwardj increasedmortalityamonghivpositivemenonantiretroviraltherapysurvivaldifferencesbetweensexesexplainedbylateinitiationinuganda